全文获取类型
收费全文 | 7461篇 |
免费 | 720篇 |
国内免费 | 824篇 |
出版年
2024年 | 13篇 |
2023年 | 148篇 |
2022年 | 191篇 |
2021年 | 419篇 |
2020年 | 334篇 |
2019年 | 465篇 |
2018年 | 388篇 |
2017年 | 271篇 |
2016年 | 387篇 |
2015年 | 522篇 |
2014年 | 591篇 |
2013年 | 621篇 |
2012年 | 681篇 |
2011年 | 583篇 |
2010年 | 358篇 |
2009年 | 330篇 |
2008年 | 362篇 |
2007年 | 313篇 |
2006年 | 290篇 |
2005年 | 206篇 |
2004年 | 237篇 |
2003年 | 204篇 |
2002年 | 163篇 |
2001年 | 154篇 |
2000年 | 116篇 |
1999年 | 93篇 |
1998年 | 73篇 |
1997年 | 53篇 |
1996年 | 80篇 |
1995年 | 64篇 |
1994年 | 50篇 |
1993年 | 27篇 |
1992年 | 42篇 |
1991年 | 32篇 |
1990年 | 31篇 |
1989年 | 21篇 |
1988年 | 24篇 |
1987年 | 16篇 |
1986年 | 12篇 |
1985年 | 18篇 |
1984年 | 6篇 |
1983年 | 7篇 |
1982年 | 5篇 |
1981年 | 4篇 |
排序方式: 共有9005条查询结果,搜索用时 15 毫秒
41.
42.
43.
Wenjuan Ding Fangfang Wang Qingwen Li Yaxin Xue Zhitong Dong Danmei Tian Mei Chen Youwei Zhang Kui Hong Jinshan Tang 《化学与生物多样性》2021,18(7):e2100229
Marine derived fungus has gained increasing ground in the discovery of novel lead compounds with potent biological activities including anti-inflammation. Here, we first report the characterization of one new sorbicillinoid ( 1 ) and fourteen known compounds ( 2 – 15 ) from the ethyl acetate (AcOEt) extract of a cultured mangrove derived fungus Penicillium sp. DM815 by UV, IR, HR ESI-Q-TOF MS, and NMR spectra. We then evaluated the anti-inflammatory effects of eleven sorbicillinoids ( 1 – 11 ) using cultured macrophage RAW264.7 cells. The results show that compound 9 , and to a lesser degree compound 5 , significantly inhibited the Gram-negative bacteria lipopolysaccharide (LPS)-induced upregulation of the inducible nitric oxide synthase (iNOS). Consistently, compounds 5 and 9 significantly reduced the level of nitric oxide (NO), the product of iNOS, induced by LPS. We further show that these two compounds dose-dependently inhibited LPS-triggered iNOS expression and NO production, but had no effect on proliferation of RAW264.7 cells in the presence of LPS. In conclusion, our study identifies novel and known sorbicillinoids as potent anti-inflammatory agents, holding the promise of developing novel anti-inflammation treatment in the future. 相似文献
44.
Yijiang Huang Xiumeng Zhang Jingdi Zhan Zijiang Yan Daosen Chen Xinghe Xue Xiaoyun Pan 《Journal of cellular and molecular medicine》2021,25(16):7734-7745
MicroRNAs (miRNAs) serve as gene silencers involved in essential cell functions. The role of miR-206 and E74-like factor 3 (Elf3) has been identified in osteoarthritis (OA), while the effect of exosomal miR-206 from bone marrow mesenchymal stem cells (BMSCs) in OA remains largely unknown. Thus, we aim to explore the role of exosomal miR-206 from BMSCs in OA with the involvement of Elf3. BMSCs and BMSC-derived exosomes (BMSC-exos) were obtained and identified. OA mouse models were constructed by anterior cruciate ligament transection and then treated with BMSC-exos or BMSC-exos containing miR-206 mimic/inhibitor. The expression of miR-206, Elf3, inflammatory factors, osteocalcin (OCN) and bone morphogenetic protein 2 (BMP2) in mouse femoral tissues was assessed. The pathological changes in mouse femur tissues were observed. The mouse osteoblasts were identified and treated with untransfected or transfected BMSC-exos, and then, the expression of miR-206, Elf3, OCN and BMP2 was determined. The alkaline phosphatase (ALP) activity, calcium deposition level, OCN secretion, proliferation, apoptosis and cell cycle arrest in osteoblasts were measured. MiR-206 was down-regulated while Elf3 was up-regulated in OA animal and cellular models. Exosomal miR-206 ameliorated inflammation and increased expression of OCN and BMP2 in mouse femoral tissues. Moreover, exosomal miR-206 promoted ALP activity, calcium deposition level, OCN secretion and proliferation and inhibited apoptosis in OA osteoblasts. Overexpressed Elf3 reversed miR-206 up-regulation-induced effects on OA osteoblasts. BMSC-derived exosomal miR-206 promotes proliferation and differentiation of osteoblasts in OA by reducing Elf3. Our research may provide novel targets for OA treatment. 相似文献
45.
46.
47.
48.
Guang Yuan Shao-Feng Yan Hao Xue Ping Zhang Jin-Tang Sun Gang Li 《The Journal of biological chemistry》2014,289(15):10607-10619
There is an urgent need for new therapeutic avenues to improve the outcome of patients with glioblastoma multiforme (GBM). Current studies have suggested that cucurbitacin I, a natural selective inhibitor of JAK2/STAT3, has a potent anticancer effect on a variety of cancer cell types. This study showed that autophagy and apoptosis were induced by cucurbitacin I. Exposure of GBM cells to cucurbitacin I resulted in pronounced apoptotic cell death through activating bcl-2 family proteins. Cells treatment with cucurbitacin I up-regulated Beclin 1 and triggered autophagosome formation and accumulation as well as conversion of LC3I to LC3II. Activation of the AMP-activated protein kinase/mammalian target of rapamycin/p70S6K pathway, but not the PI3K/AKT pathway, occurred in autophagy induced by cucurbitacin I, which was accompanied by decreased hypoxia-inducible factor 1α. Stable overexpression of hypoxia-inducible factor 1α induced by FG-4497 prevented cucurbitacin I-induced autophagy and down-regulation of bcl-2. Knockdown of beclin 1 or treatment with the autophagy inhibitor 3-methyladenine also inhibited autophagy induced by cucurbitacin I. A coimmunoprecipitation assay showed that the interaction of Bcl-2 and Beclin 1/hVps34 decreased markedly in cells treated with cucurbitacin I. Furthermore, knockdown of beclin 1 or treatment with the lysosome inhibitor chloroquine sensitized cancer cells to cucurbitacin I-induced apoptosis. Finally, a xenograft model provided additional evidence for the occurrence of cucurbitacin I-induced apoptosis and autophagy in vitro. Our findings provide new insights into the molecular mechanisms underlying cucurbitacin I-mediated GBM cell death and may provide an efficacious therapy for patients harboring GBM. 相似文献
49.
J L Huret H Mossafa A Brizard B Dreyfus F Guilhot X Q Xue P Babin J Tanzer 《Annales de génétique》1989,32(3):155-159
We report on 33 unpublished patients with clonal anomalies in chronic lymphocytic leukaemia. The literature was thoroughly reviewed in order 1) to quantify the frequency of anomalies found in chronic lymphocytic leukaemia and to give new status to the rarest, 2) to determine whether a given anomaly was an additional anomaly and/or a primary anomaly, and 3) to find out whether strong associations between different anomalies exist in this disease. 相似文献
50.